Company
Exelixis
Building next-generation oncology franchises
Also known as Exelixis, Inc.
- Status
- IPOas of 2026-09-17Source (opens in a new tab)
- Business model
- B2B
- Headquarters
- Alameda, CA, United States
- Founded
- 1994
- Customers
- physicians and patients
- Legal name
- Exelixis, Inc.
- exelixis.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Record updated 17 September 2026
About
At Exelixis, cancer is our cause. Over the course of the past three decades, we’ve evolved into a multi-platform cancer company dedicated to creating treatment regimens that challenge the status quo and bring us closer to a potential cure – all to give more patients hope for the future.
Funding snapshot
- Latest round
- Round2009-06-10
Funding rounds
- Round, 2009
- 2009-06-101 investor
About the company
- Status notes
- Stock Information
Products
- Other
- CABOMETYX (cabozantinib)